These findings support the notion that IGF2BP2-SE exerts a positive regulatory role in maintaining the functional characteristics of HNSCC by governing the transcriptional expression of IGF2BP2. The gene discussed is IGF2BP2; the disease is head and neck squamous cell carcinoma.